Nathaniel Garry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nathaniel Garry has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
A. Lorelei Golas
Broad Institute of MIT and Harvard; Cambridge, Massachusetts, USA
1 shared publicationAlan Zhong
Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14850, USA
1 shared publicationAllison Lemmer
Broad Institute of MIT and Harvard; Cambridge, Massachusetts, USA
1 shared publication- Austin N. Bond
Broad Institute of MIT and Harvard; Cambridge, Massachusetts, USA
1 shared publication - Christopher M. Sassetti
Department of Microbiology and Physiological Systems, UMass Chan Medical School
1 shared publication - Cédric Feschotte
Department of Molecular Biology and Genetics, Cornell University
1 shared publication
Latest Publications
- Open Access
- 3 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis
We previously reported an antibiotic discovery screening platform that identifies whole-cell active compounds with high sensitivity while simultaneously providing mechanistic insight, necessary for hit prioritization. Named PROSPECT, (PRimary screening Of Strains to Prioritize Expanded Chemistry and Targets), this platform measures chemical-genetic interactions between small molecules and pooled Mycobacterium tuberculosis mutants, each depleted of a different essential protein. Here, we introduce Perturbagen CLass (PCL) analysis, a computational method that infers a compound’s mechanism-of-action (MOA) by comparing its chemical-genetic interaction profile to those of a curated reference set of 437 known molecules. In leave-one-out cross-validation, we correctly predict MOA with 70% sensitivity and 75% precision, and achieve comparable results (69% sensitivity, 87% precision) with a test set of 75 antitubercular compounds with known MOA previously reported by GlaxoSmithKline (GSK). From 98 additional GSK antitubercular compounds with unknown MOA, we predict 60 to act via a reference MOA and functionally validate 29 compounds predicted to target respiration. Finally, from a set of ~5,000 compounds from larger unbiased libraries, we identify a novel QcrB-targeting scaffold that initially lacked wild-type activity, experimentally confirming this prediction while chemically optimizing this scaffold. PCL analysis of PROSPECT data enables rapid MOA assignment and hit prioritization, streamlining antimicrobial discovery.
- 3 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessReference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis
We previously reported an antibiotic discovery screening platform that identifies whole-cell active compounds with high sensitivity while simultaneously providing mechanistic insight, necessary for hit prioritization. Named PROSPECT, (PRimary screening Of Strains to Prioritize Expanded Chemistry and Targets), this platform measures chemical-genetic interactions between small molecules and pooled Mycobacterium tuberculosis mutants, each depleted of a different essential protein. Here, we introduce Perturbagen CLass (PCL) analysis, a computational method that infers a compound’s mechanism-of-action (MOA) by comparing its chemical-genetic interaction profile to those of a curated reference set of 437 known molecules. In leave-one-out cross-validation, we correctly predict MOA with 70% sensitivity and 75% precision, and achieve comparable results (69% sensitivity, 87% precision) with a test set of 75 antitubercular compounds with known MOA previously reported by GlaxoSmithKline (GSK). From 98 additional GSK antitubercular compounds with unknown MOA, we predict 60 to act via a reference MOA and functionally validate 29 compounds predicted to target respiration. Finally, from a set of ~5,000 compounds from larger unbiased libraries, we identify a novel QcrB-targeting scaffold that initially lacked wild-type activity, experimentally confirming this prediction while chemically optimizing this scaffold. PCL analysis of PROSPECT data enables rapid MOA assignment and hit prioritization, streamlining antimicrobial discovery.
- Top Cited Papers
- 19 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6531) , 797-+
Recurrent evolution of vertebrate transcription factors by transposase capture
A recipe for new genes: Most lineages contain evolutionarily novel genes, but their origin is not always clear. Cosby et al. investigated the origin of families of lineage-specific vertebrate genes (see the Perspective by Wacholder and Carvunis). Fusion between transposable elements (TEs) and host gene exons, once incorporated into the host genome, could generate new functional genes. Examination of KARABINER , a bat gene that arose through this process, shows how the retention of part of the TE within this gene allows the transcribed protein to bind throughout the genome and act as a transcriptional regulator. Thus, TEs interacting within their host genome provide the raw material to generate new combinations of functional domains that can be selected upon and incorporated within the hierarchical cellular network. Science , this issue p. eabc6405 ; see also p. 779
- 19 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6531) , 797-+
Top Cited PapersRecurrent evolution of vertebrate transcription factors by transposase capture
A recipe for new genes: Most lineages contain evolutionarily novel genes, but their origin is not always clear. Cosby et al. investigated the origin of families of lineage-specific vertebrate genes (see the Perspective by Wacholder and Carvunis). Fusion between transposable elements (TEs) and host gene exons, once incorporated into the host genome, could generate new functional genes. Examination of KARABINER , a bat gene that arose through this process, shows how the retention of part of the TE within this gene allows the transcribed protein to bind throughout the genome and act as a transcriptional regulator. Thus, TEs interacting within their host genome provide the raw material to generate new combinations of functional domains that can be selected upon and incorporated within the hierarchical cellular network. Science , this issue p. eabc6405 ; see also p. 779